70 results on '"Babu, K Govind"'
Search Results
2. Indian clinical practice consensus guidelines for the management of very advanced head-and-neck squamous cell carcinoma: Update 2022
3. Indian clinical practice consensus guidelines for the management of hypopharyngeal cancer: Update 2022
4. Indian clinical practice consensus guidelines for the management of oral cavity cancer: Update 2022
5. Indian clinical practice consensus guidelines for the management of laryngeal cancer: Update 2022
6. Indian clinical practice post-treatment imaging guidelines for head-and-neck cancers
7. Indian clinical practice consensus guidelines for the management of oropharyngeal cancer: Update 2022
8. Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022
9. Introduction to Indian clinical practice consensus guidelines for the management of squamous cell carcinoma the head-and-neck: Update 2022
10. Indian clinical practice pre-treatment imaging guidelines for head-and-neck cancers
11. Efficacy and Safety of Nuvastatic™ in Improving Cancer-related Fatigue: A Phase II Multicenter Randomized Controlled Trial
12. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
13. Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
14. Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer
15. Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
16. Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region
17. Abstract PD2-04: Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib
18. South Asian Declaration—Consensus Guidelines for COVID-19 Vaccination in Cancer Patients
19. “Choosing Wisely” for Cancer Care in India
20. Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
21. “Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic
22. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
23. Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection
24. A Novel Ex Vivo System Using 3D Polymer Scaffold to Culture Circulating Tumor Cells from Breast Cancer Patients Exhibits Dynamic E-M Phenotypes
25. Metastatic Synovial Sarcoma: Experience from a Tertiary Care Center from India
26. Pattern of Bone Marrow Involvement by Solid Tumors: Experience from a Tertiary Care Center from South India
27. Efficacy of a Reduced-dose Rasburicase: Single-institution Experience in India
28. Report on Our Publication in Science Reports
29. Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care
30. Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study
31. Liquid biopsy when MEAT is not the treat
32. Selective cyclin-dependent kinase 4/6 inhibitors as anticancer drugs: Moving beyond hormone receptor-positive breast cancer
33. Epithelioid Sarcoma Presenting as Recurrent Thumb Ulcer: A Lesson to Learn
34. Clinical profile and treatment outcomes of metastatic neuroendocrine carcinoma: A single institution experience
35. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
36. Correlation of BMI with breast cancer subtype and tumour size
37. Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma
38. Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
39. Metastatic gastrointestinal stromal tumor: A regional cancer center experience of 44 cases
40. Clinicopathological profile and treatment outcome of squamous cell carcinoma breast at a tertiary cancer center in South India
41. Disorders of taste (dysgeusia) in head and neck cancer patients on concomitant CT/RT.
42. Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India
43. Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India
44. Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India
45. Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial
46. Outcomes, cost comparison, and patient satisfaction during long-term central venous access in cancer patients: Experience from a Tertiary Care Cancer Institute in South India
47. Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL
48. Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years
49. Cancer-associated thrombotic microangiopathy
50. Health-Related Quality of Life and Patient-Reported Outcomes in Patients Receiving Ofatumumab in Combination with Fludarabine and Cyclophosphamide (FC) Versus FC Alone in the Complement 2 Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.